| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.098 | 0.007 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.44 | 0.009 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.009 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.009 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.009 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |